These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 11899912

  • 1. TGF-beta3 in the treatment of pressure ulcers: a preliminary report.
    Hirshberg J, Coleman J, Marchant B, Rees RS.
    Adv Skin Wound Care; 2001; 14(2):91-5. PubMed ID: 11899912
    [Abstract] [Full Text] [Related]

  • 2. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study.
    Rees RS, Robson MC, Smiell JM, Perry BH.
    Wound Repair Regen; 1999; 7(3):141-7. PubMed ID: 10417749
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers in elderly patients: results of a randomized controlled trial.
    Meaume S, Kerihuel JC, Constans T, Teot L, Lerebours E, Kern J, Bourdel Marchasson I.
    J Nutr Health Aging; 2009 Aug; 13(7):623-30. PubMed ID: 19621198
    [Abstract] [Full Text] [Related]

  • 4. A Randomized, Controlled Trial to Assess the Effect of Topical Insulin Versus Normal Saline in Pressure Ulcer Healing.
    Stephen S, Agnihotri M, Kaur S.
    Ostomy Wound Manage; 2016 Jun; 62(6):16-23. PubMed ID: 27356143
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies.
    Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH.
    Wound Repair Regen; 1999 Jun; 7(5):335-46. PubMed ID: 10564562
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
    Hanft JR, Pollak RA, Barbul A, van Gils C, Kwon PS, Gray SM, Lynch CJ, Semba CP, Breen TJ.
    J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954
    [Abstract] [Full Text] [Related]

  • 7. Role of TGF-β3 in modulating inflammatory responses and wound healing processes in ischemic ulcers in atherosclerotic patients.
    Ma TY, Tang SL, Wang B, Wang G, Sun CM, Pan JX, Han DQ, Li JY, Zhong JH.
    Int Wound J; 2024 Feb; 21(2):e14762. PubMed ID: 38356162
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of topical atorvastatin for the treatment of pressure ulcers: a randomized clinical trial.
    Farsaei S, Khalili H, Farboud ES, Karimzadeh I, Beigmohammadi MT.
    Pharmacotherapy; 2014 Jan; 34(1):19-27. PubMed ID: 23940000
    [Abstract] [Full Text] [Related]

  • 9. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.
    Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF.
    Lancet; 1992 Jan 04; 339(8784):23-5. PubMed ID: 1345953
    [Abstract] [Full Text] [Related]

  • 10. Topical treatment of pressure ulcers with nerve growth factor: a randomized clinical trial.
    Landi F, Aloe L, Russo A, Cesari M, Onder G, Bonini S, Carbonin PU, Bernabei R.
    Ann Intern Med; 2003 Oct 21; 139(8):635-41. PubMed ID: 14568851
    [Abstract] [Full Text] [Related]

  • 11. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.
    Mustoe TA, Cutler NR, Allman RM, Goode PS, Deuel TF, Prause JA, Bear M, Serdar CM, Pierce GF.
    Arch Surg; 1994 Feb 21; 129(2):213-9. PubMed ID: 8304833
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ, Smiell JM, Su Y.
    Diabetes Care; 1998 May 21; 21(5):822-7. PubMed ID: 9589248
    [Abstract] [Full Text] [Related]

  • 13. NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.
    Balingit PP, Armstrong DG, Reyzelman AM, Bolton L, Verco SJ, Rodgers KE, Nigh KA, diZerega GS.
    Wound Repair Regen; 2012 May 21; 20(4):482-90. PubMed ID: 22672145
    [Abstract] [Full Text] [Related]

  • 14. Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors.
    Foncuberta MC, Cagnoni PJ, Brandts CH, Mandanas R, Fields K, Derigs HG, Reed E, Sonis ST, Fay J, LeVeque F, Pouillart P, Schrezenmeier H, Emmons R, Thiel E, Investigators in TGF-beta3/OM Study Protocols 203/205.
    J Immunother; 2001 May 21; 24(4):384-8. PubMed ID: 11565840
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta3-loaded microtextured membranes for skin regeneration in dermal wounds.
    Vooijs DP, Walboomers XF, Parker JA, Von den Hoff JW, Jansen JA.
    J Biomed Mater Res A; 2004 Sep 01; 70(3):402-11. PubMed ID: 15293313
    [Abstract] [Full Text] [Related]

  • 16. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers.
    Kallianinen LK, Hirshberg J, Marchant B, Rees RS.
    Plast Reconstr Surg; 2000 Nov 01; 106(6):1243-8. PubMed ID: 11083552
    [Abstract] [Full Text] [Related]

  • 17. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
    Park KH, Han SH, Hong JP, Han SK, Lee DH, Kim BS, Ahn JH, Lee JW.
    Diabetes Res Clin Pract; 2018 Aug 01; 142():335-344. PubMed ID: 29902542
    [Abstract] [Full Text] [Related]

  • 18. Acceleration of wound healing in gastric ulcers by local injection of neutralising antibody to transforming growth factor beta 1.
    Ernst H, Konturek P, Hahn EG, Brzozowski T, Konturek SJ.
    Gut; 1996 Aug 01; 39(2):172-5. PubMed ID: 8991853
    [Abstract] [Full Text] [Related]

  • 19. Pressure ulcer healing with a concentrated, fortified, collagen protein hydrolysate supplement: a randomized controlled trial.
    Lee SK, Posthauer ME, Dorner B, Redovian V, Maloney MJ.
    Adv Skin Wound Care; 2006 Mar 01; 19(2):92-6. PubMed ID: 16557055
    [Abstract] [Full Text] [Related]

  • 20. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
    Senet P, Bon FX, Benbunan M, Bussel A, Traineau R, Calvo F, Dubertret L, Dosquet C.
    J Vasc Surg; 2003 Dec 01; 38(6):1342-8. PubMed ID: 14681639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.